Literature DB >> 25586871

Whole arm deletions of 18p: medical and developmental effects.

Courtney Sebold1, Bridgette Soileau, Patricia Heard, Erika Carter, Louise O'Donnell, Daniel E Hale, Jannine D Cody.   

Abstract

Deletions of the short arm of chromosome 18 have been well-described in case reports. However, the utility of these descriptions in clinical practice is limited by varied and imprecise breakpoints. As we work to establish genotype-phenotype correlations for 18p-, it is critical to have accurate and complete clinical descriptions of individuals with differing breakpoints. In addition, the developmental profile of 18p- has not been well-delineated. We undertook a thorough review of the medical histories of 31 individuals with 18p- and a breakpoint in the centromeric region. We collected developmental data using mailed surveys and questionnaires. The most common findings included neonatal complications; cardiac anomalies; hypotonia; MRI abnormalities; endocrine dysfunction; strabismus; ptosis; and refractive errors. Less common features included holoprosencephaly and its microforms; hearing loss; and orthopedic anomalies. The developmental effects of the deletion appear to be less severe than reported in the literature, as average IQ scores were in the range of borderline intellectual functioning. Based on responses to standardized questionnaires, it appears this population has marked difficulty with activities of daily living, though several young adults were able to live independent of their parents. This manuscript represents the most comprehensive description of a cohort of 18p- individuals with identical breakpoints. Despite identical breakpoints, a great deal of phenotype variability remained among this population, suggesting that many of the genes on 18p- cause low-penetrance phenotypes when present in a hemizygous state. Future efforts will focus on the clinical description of individuals with more distal breakpoints and the identification of critical regions and candidate genes.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  18p-; chromosome 18; deletion 18p

Mesh:

Year:  2015        PMID: 25586871     DOI: 10.1002/ajmg.a.36880

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  6 in total

1.  Chromosome 18 gene dosage map 2.0.

Authors:  Jannine D Cody; Patricia Heard; David Rupert; Minire Hasi-Zogaj; Annice Hill; Courtney Sebold; Daniel E Hale
Journal:  Hum Genet       Date:  2018-11-17       Impact factor: 4.132

2.  Hemizygosity for SMCHD1 in Facioscapulohumeral Muscular Dystrophy Type 2: Consequences for 18p Deletion Syndrome.

Authors:  Richard J L F Lemmers; Marlinde L van den Boogaard; Patrick J van der Vliet; Colleen M Donlin-Smith; Sharon P Nations; Claudia A L Ruivenkamp; Patricia Heard; Bert Bakker; Stephen Tapscott; Jannine D Cody; Rabi Tawil; Silvère M van der Maarel
Journal:  Hum Mutat       Date:  2015-05-20       Impact factor: 4.878

3.  The genotype and phenotype of chromosome 18p deletion syndrome: Case series.

Authors:  Qiujie Jin; Rong Qiang; Bo Cai; Xiaobin Wang; Na Cai; Shuai Zhen; Wen Zhai
Journal:  Medicine (Baltimore)       Date:  2021-05-07       Impact factor: 1.889

4.  Anterior Pituitary Aplasia in an Infant with Ring Chromosome 18p Deletion.

Authors:  Edward J Bellfield; Jacqueline Chan; Sarah Durrin; Valerie Lindgren; Zohra Shad; Claudia Boucher-Berry
Journal:  Case Rep Endocrinol       Date:  2016-10-24

5.  Prenatal diagnosis of de novo monosomy 18p deletion syndrome by chromosome microarray analysis: Three case reports.

Authors:  Hong Qi; Jianjiang Zhu; Shaoqin Zhang; Lirong Cai; Xiaohui Wen; Wen Zeng; Guodong Tang; Yao Luo
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

6.  Human Chromosome 18 and Acrocentrics: A Dangerous Liaison.

Authors:  Nicoletta Villa; Serena Redaelli; Elena Sala; Donatella Conconi; Lorenza Romitti; Emanuela Manfredini; Francesca Crosti; Gaia Roversi; Marialuisa Lavitrano; Ornella Rodeschini; Maria Paola Recalcati; Rocco Piazza; Leda Dalprà; Paola Riva; Angela Bentivegna
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.